Literature DB >> 17030198

AGA Institute medical position statement on the use of endoscopic therapy for gastroesophageal reflux disease.

Gary W Falk1, M Brian Fennerty, Richard I Rothstein.   

Abstract

This document presents the official recommendations of the AGA Institute on "Endoscopic Therapy for Gastroesophageal Reflux Disease." It was approved by the Clinical Practice and Economics Committee on June 20, 2006, and by the AGA Institute Governing Board on July 24, 2006.

Entities:  

Mesh：

Year:  2006        PMID： 17030198     DOI： 10.1053/j.gastro.2006.08.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


  4 in total

Review 1.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

2.  Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment.

Authors:  James P Franciosi; Edward B Mougey; Andre Williams; Roberto A Gomez Suarez; Cameron Thomas; Christa L Creech; Katherine George; Diana Corao; John J Lima
Journal:  Eur J Pediatr       Date:  2017-12-06       Impact factor: 3.183

3.  Endoluminal fundoplication by a transoral device for the treatment of GERD: A feasibility study.

Authors:  G B Cadière; A Rajan; O Germay; J Himpens
Journal:  Surg Endosc       Date:  2007-12-11       Impact factor: 4.584

Review 4.  Endoscopic anti-reflux therapy for gastroesophageal reflux disease.

Authors:  Enrique Rodríguez de Santiago; Eduardo Albéniz; Fermin Estremera-Arevalo; Carlos Teruel Sanchez-Vegazo; Vicente Lorenzo-Zúñiga
Journal:  World J Gastroenterol       Date:  2021-10-21       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.